Hilltop National Bank Takes $156,000 Position in HCA Healthcare, Inc. $HCA

Hilltop National Bank acquired a new stake in HCA Healthcare, Inc. (NYSE:HCA) during the 2nd quarter, according to its most recent disclosure with the SEC. The fund acquired 406 shares of the company’s stock, valued at approximately $156,000.

Other institutional investors and hedge funds also recently modified their holdings of the company. Cheviot Value Management LLC acquired a new position in HCA Healthcare during the 1st quarter worth approximately $26,000. Saudi Central Bank bought a new position in HCA Healthcare in the first quarter valued at $26,000. WPG Advisers LLC acquired a new position in shares of HCA Healthcare during the 1st quarter worth about $27,000. Atwood & Palmer Inc. bought a new stake in HCA Healthcare during the first quarter worth about $28,000. Finally, Bartlett & CO. Wealth Management LLC grew its stake in HCA Healthcare by 888.9% in the first quarter. Bartlett & CO. Wealth Management LLC now owns 89 shares of the company’s stock valued at $31,000 after purchasing an additional 80 shares in the last quarter. 62.73% of the stock is owned by institutional investors and hedge funds.

HCA Healthcare Price Performance

Shares of NYSE:HCA opened at $429.52 on Friday. The company’s 50 day simple moving average is $397.53 and its 200 day simple moving average is $372.65. HCA Healthcare, Inc. has a 1 year low of $289.98 and a 1 year high of $432.36. The stock has a market capitalization of $100.50 billion, a price-to-earnings ratio of 18.05, a price-to-earnings-growth ratio of 1.35 and a beta of 1.40.

HCA Healthcare (NYSE:HCA) last issued its quarterly earnings results on Friday, July 25th. The company reported $6.84 earnings per share (EPS) for the quarter, beating the consensus estimate of $6.20 by $0.64. The company had revenue of $18.61 billion for the quarter, compared to analyst estimates of $18.49 billion. HCA Healthcare had a negative return on equity of 7,363.11% and a net margin of 8.21%.The company’s revenue for the quarter was up 6.4% compared to the same quarter last year. During the same quarter last year, the company posted $5.50 EPS. HCA Healthcare has set its FY 2025 guidance at 25.500-27.000 EPS. As a group, analysts anticipate that HCA Healthcare, Inc. will post 24.98 EPS for the current fiscal year.

HCA Healthcare Dividend Announcement

The business also recently disclosed a quarterly dividend, which was paid on Tuesday, September 30th. Investors of record on Tuesday, September 16th were given a dividend of $0.72 per share. This represents a $2.88 dividend on an annualized basis and a yield of 0.7%. The ex-dividend date was Tuesday, September 16th. HCA Healthcare’s dividend payout ratio is currently 12.11%.

Analyst Upgrades and Downgrades

Several equities analysts recently weighed in on the stock. Weiss Ratings reissued a “buy (b-)” rating on shares of HCA Healthcare in a research note on Saturday, September 27th. Robert W. Baird upped their target price on shares of HCA Healthcare from $380.00 to $423.00 and gave the company a “neutral” rating in a report on Thursday, August 14th. Morgan Stanley reduced their price target on HCA Healthcare from $410.00 to $400.00 and set an “equal weight” rating for the company in a report on Monday, July 28th. Wolfe Research cut HCA Healthcare from an “outperform” rating to a “peer perform” rating in a research report on Monday, July 28th. Finally, Wall Street Zen raised HCA Healthcare from a “hold” rating to a “buy” rating in a report on Saturday, July 5th. One research analyst has rated the stock with a Strong Buy rating, eight have given a Buy rating and nine have given a Hold rating to the company’s stock. Based on data from MarketBeat.com, HCA Healthcare currently has an average rating of “Moderate Buy” and an average target price of $407.75.

Insider Buying and Selling at HCA Healthcare

In other news, EVP Michael S. Cuffe sold 3,836 shares of the company’s stock in a transaction on Monday, September 8th. The shares were sold at an average price of $418.84, for a total transaction of $1,606,670.24. Following the completion of the transaction, the executive vice president directly owned 31,503 shares in the company, valued at approximately $13,194,716.52. This represents a 10.85% decrease in their ownership of the stock. The sale was disclosed in a filing with the Securities & Exchange Commission, which is accessible through the SEC website. Insiders own 1.30% of the company’s stock.

HCA Healthcare Profile

HCA Healthcare, Inc, through its subsidiaries, owns and operates hospitals and related healthcare entities in the United States. It operates general and acute care hospitals that offers medical and surgical services, including inpatient care, intensive care, cardiac care, diagnostic, and emergency services; and outpatient services, such as outpatient surgery, laboratory, radiology, respiratory therapy, cardiology, and physical therapy.